Test to Identify if Early Dementia Will Develop into Alzheimer's

Test to Identify if Early Dementia Will Develop into Alzheimer's

Researchers have found that a combination of proteins in the cerebrospinal fluid can reliably identify which patients with early symptoms of dementia will subsequently develop full-blown Alzheimer's disease.

Small single-center studies have shown that cerebrospinal fluid (CSF) biomarkers may be useful to identify incipient Alzheimer’s disease in patients with mild cognitive impairment, but large-scale multicenter studies have not been conducted.

Alzheimer's disease is the most common dementia disorder, with an estimated 5.3 million Americans living with Alzheimer’s.

There is currently no cure for Alzheimer’s disease, but available treatments could have the greatest effect if they are used from an early stage, so methods are needed for early diagnosis of Alzheimer’s.

Changes in the brain are reflected in the CSF in the form of biomarkers. Previous smaller studies have shown that the proteins beta-amyloid, tau and phosphorylated tau in the CSF can be used to make an early diagnosis of Alzheimer's disease.

Dr Niklas Mattsson and colleagues at hospitals in Sweden, elsewhere in Europe and the USA have confirmed this in a large multicentre study with more than 1,500 participants.

"These methods make it easier to identify the disease, which is essential for making a correct diagnosis early on," he says.
References:
1. Niklas Mattsson, et al. CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment. JAMA. 2009;302(4):385-393.

Software Developed That Analyzes MR Images to Diagnose Alzheimer’s

Researchers have developed software to analyze MRI studies of the brain that could allow diagnosis of Alzheimer's and of mild cognitive impairment, a lesser form of dementia that precedes the

Alzheimer's Disease Linked to Mitochondrial Damage

Researchers have demonstrated that attacks on the mitochondrial protein Drp1 by the free radical nitric oxide, which causes a chemical reaction called S-nitrosylation, mediates

Protein Identified as Factor in Alzheimer's Disease Development

Inheritance of an extra copy of the gene- β -amyloid precursor protein, APP, in individuals with Down syndrome leads to the inevitable development of early onset Alzheimer's disease, known to

The Association between Smoking and Alzheimer's Risk

Some studies have suggested a protective effect of smoking on Alzheimer's. Meta-analyses of case-control and cohort studies to investigate the risk of Alzheimer's associated with smoking found

Rapid Loss of Weight in Elderly Could Be a Sign of Dementia

New research shows that the elderly who are thinner or are losing weight rapidly are at a higher risk of developing dementia, especially if they were overweight or obese. The researchers